Raja Muda of Selangor, Tengku Amir Shah ibni Sultan Sharafuddin Idris Shah Alhaj, is back with the launch of the Selangor Biotechnology Action Plan 2021-2030 in conjunction with the Selangor International Business Summit (SIBS) 2021.
University Putra Malaysia (UPM), along with the Malaysian Biotechnology Information Center (MABIC) and the Bioeconomics Foundation, have been appointed by Invest Selangor Berhad (ISB) as advisors to develop the policy paper for the Selangor Biotechnology Action Plan 2021-2030.
Deputy Dean (Industry and Community Relations), School of Biotechnology and Biomolecular Sciences (FBSB), UPM, Prof. Ts. Dr. Hedaya Arfin, who is also the advisory project manager, said that choosing UPM as a consultant was a tribute to the UPM lecturers.
Selangor Raja Muda launches Selangor Biotechnology Business Plan
“The UPM team of lecturers went through a phased selection process that included the submission of a proposal paper to Selangor Exco and ISB management. Our group was selected as joint advisors with MABIC and Bioeconomy, two major players in Malaysia’s biotech sector.
She said that the Selangor Biotechnology Policy Paper 2021-2030 took nearly two years to develop, which started from the preparation of the proposal paper to approval in the Selangor Economic Work Council (MTES) chaired by Menteri Besar.
“In a span of two years, information was collected and defined for the biotechnology ecosystem in Selangor using various methods such as literacy surveys, stakeholder surveys, focus group discussions (FGDs) with local and foreign players in the biotech sector and gap analysis.
“This launch is a historic moment for our team. It is hoped that it will benefit the residents of Selangor in particular and Malaysians in general.”
The UPM advisors are from FBSB and the School of Business and Economics (SPE), UPM, led by Professor Dato’ Dr. Muhammad Ali Hassan, followed by Professor Datin Paduka Dr. Khatija Yusuf, Assistant. Prof. Dr. Mohamed Dhu El Khairy Mohamed Youssef Mosaed. Prof. Dr. Mohamed Rafeen Zakaria, Assistant. Prof. Dr. Nourati Ramli Assistant. Muhammad Faisal Ibrahim, d. Ahmed Muhaimin Roslan, d. Izana Kamal Bahrain, d. Farah Nadia Mohamed Bazil, Prof.Dr. Shafeeq Fahmy Ahmed Seddik (SPE); Dr.. Dr. Muhammad Dhani Abdul Rahman (SPE) and Dr. Noor Azlin Ismail (SPE).
Professor Ts. Dr Hedaya said the action plan incorporates the state government’s commitment and ambition to make Selangor the center of biotechnology and bio-economy in Southeast Asia.
“Selangor has a vision of making the biotechnology sector a key driver of the economy. The Selangor Biotechnology Action Plan 2021-2030 establishes biotechnology-related governance to decide policy, implement and monitor strategies and initiatives for the biotechnology sector in Selangor.”
Meanwhile, Professor Ts. Dr.. Hedaya and Vice President of the Foundation for Bioeconomics Datin Aznita Nazis.
It was intended to provide information to the biotechnology stakeholders in Malaysia regarding the drivers, objectives, action plans and initiatives presented in the Selangor Biotechnology Action Plan 2021-2030 policy paper.
The policy paper contains five axes, 10 goals, 35 action plans and 43 initiatives that are being implemented by various agencies of the state government and led by the implementation unit established under Invest Selangor Berhad. – UPM
